News
News
- New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress
05/14/2020 / 15:02 - GlobeNewswire - TRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
05/13/2020 / 22:04 - GlobeNewswire - Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
05/13/2020 / 13:00 - GlobeNewswire - Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
05/13/2020 / 08:00 - GlobeNewswire - CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001™ for the Treatment of Severe Hemoglobinopathies
05/11/2020 / 15:00 - GlobeNewswire - OpGen CEO and Chairman of the Board Issue Letters to Stockholders
05/11/2020 / 13:30 - GlobeNewswire - CRISPR Therapeutics to Present at the Bank of America Securities 2020 Health Care Conference
05/07/2020 / 14:00 - GlobeNewswire - Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020
05/06/2020 / 22:30 - GlobeNewswire - Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments
05/06/2020 / 22:05 - GlobeNewswire - Prothena Reports First Quarter 2020 Financial Results and Provides R&D Update and Updated Financial Guidance
05/06/2020 / 22:05 - GlobeNewswire
Real-time